- Article metrics
- Last updated: Mon, 2 Feb 2026 0:08:35 Z
Correction: Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program
Access & Citations
-
- 1316
- Article Accesses
-
- 1
- Citation
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
